Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea
이의경
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 201701
92
A comparison of discontinuation rates of tofacitinib and biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis: a systematic review and Bayesian network meta-analysis regression
이의경
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 201701
93
Cost-effectiveness Analysis of Treatment Sequence Initiating With Etanercept Compared With Leflunomide in Rheumatoid Arthritis: Impact of Reduced Etanercept Cost With Patent Expiration in South Korea
이의경
CLINICAL THERAPEUTICS, 201611
94
Assessment of the Price-Volume Agreement Program in South Korea
이의경
HEALTH POLICY, 201610
95
Comparison of Effectiveness Between Delamanid and Bedaquiline Among Patients with Multidrug-Resistant Tuberculosis: A Markov Model Simulation Study
이의경
CLINICAL DRUG INVESTIGATION, 201607
96
A benefit-risk assessment model for statins using multicriteria decision analysis based on a discrete choice experiment in Korean patients
이의경
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 201606
97
Factors influencing the difference between forecasted and actual drug sales volumes under the price-volume agreement in South Korea
이의경
HEALTH POLICY, 201606
98
Effect of sex and age on the association between suicidal behaviour and obesity in Korean adults: a cross-sectional nationwide study
이의경
BMJ OPEN, 201606
99
Comparison of benefit-risk preferences of patients and physicians regarding cyclooxygenase-2 inhibitors using discrete choice experiments
이의경
PATIENT PREFERENCE AND ADHERENCE, 201604
100
Higher prevalence of dementia in patients with schizophrenia: A nationwide population-based study